Related references
Note: Only part of the references are listed.Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia
Matteo Marchetti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review
John A. Dougherty et al.
ANNALS OF PHARMACOTHERAPY (2021)
Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management
Matteo Marchetti et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Survey of Practice Pattern in Patients With Heparin-Induced Thrombocytopenia Requiring Cardiopulmonary Bypass
Alycia Wanat-Hawthorne et al.
ANESTHESIA AND ANALGESIA (2021)
How would we treat our own heparin-induced thrombocytopenia during cardiac surgery?
Andreas Koster et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2021)
Potential and Limitations of the New P2Y12Inhibitor, Cangrelor, in Preventing Heparin-Induced Platelet Aggregation During Cardiac Surgery: An In Vitro Study
Emmanuelle Scala et al.
ANESTHESIA AND ANALGESIA (2020)
Sensitivity of Viscoelastic Tests to Platelet Function
Marco Ranucci et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: Lessons from therapeutic modalities targeting Fcγ receptors
Anthony Shock et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Effect of Prostanoids on Human Platelet Function: An Overview
Steffen Braune et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Novel Use of Cangrelor With Heparin During Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Who Require Cardiovascular Surgery: A Case Series
Yan K. Gernhofer et al.
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY (2020)
High-dose IVIG plus cangrelor platelet anesthesia during urgent heparin-CPB in a patient with recent SRA-negative HIT-thrombosis with persisting platelet-activating antibodies
Andreas Koster et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Is 300 Seconds ACT Safe and Efficient during MiECC Procedures?
Adrian Bauer et al.
THORACIC AND CARDIOVASCULAR SURGEON (2019)
The Use of Cangrelor and Heparin for Anticoagulation in a Patient Requiring Pulmonary Thromboendarterectomy Surgery with Suspected Heparin-Induced Thrombocytopenia
Scott Seider et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2019)
Safety and efficacy of Tirofiban in STEMI-patients
Lisa Dannenberg et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Alteration in GPIIb/IIIa Binding of VWD-Associated von Willebrand Factor Variants with C-Terminal Missense Mutations
Gesa Koenig et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Cardiac Surgery Successfully Managed With Cangrelor in a Patient With Persistent Anti-PF4/Heparin Antibodies 8 Years After Heparin-Induced Thrombocytopenia
Emmanuelle Scala et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2019)
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review
Theodore E. Warkentin
EXPERT REVIEW OF HEMATOLOGY (2019)
Successful Use of Cangrelor and Heparin for Cardiopulmonary Bypass in a Patient With Heparin-Induced Thrombocytopenia and End-Stage Renal Disease: A Case Report
Alexander M. Girgis et al.
A & A PRACTICE (2019)
The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines-Anticoagulation During Cardiopulmonary Bypass
Linda Shore-Lesserson et al.
ANESTHESIA AND ANALGESIA (2018)
Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery
Andreas Koster et al.
ANESTHESIOLOGY (2018)
Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review
C. Boer et al.
BRITISH JOURNAL OF ANAESTHESIA (2018)
The use of cangrelor with heparin for left ventricular assist device implantation in a patient with acute heparin-induced thrombocytopenia
Yan K. Gernhofer et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2018)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
Adam Cuker et al.
BLOOD ADVANCES (2018)
Prostacyclins in Cardiac Surgery: Coming of Age
Seema P. Deshpande et al.
SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA (2018)
Autoimmune heparin-induced thrombocytopenia
A. Greinacher et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Cangrelor A New Route for P2Y 12 Inhibition
Alexandra M. Sible et al.
CARDIOLOGY IN REVIEW (2017)
The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)
Sanjay Khandelwal et al.
BLOOD (2016)
Heparin-Induced Thrombocytopenia A Comprehensive Clinical Review
Benjamin S. Salter et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Management of the multiple phases of heparin-induced thrombocytopenia
Adam Cuker
THROMBOSIS AND HAEMOSTASIS (2016)
Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): An 11-year experience
George Palatianos et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Alternatives to heparin and protamine anticoagulation for cardiopulmonary bypass in cardiac surgery
Aurore Bouraghda et al.
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2015)
The platelet Fc receptor, FcγRIIa
Jianlin Qiao et al.
IMMUNOLOGICAL REVIEWS (2015)
Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia
Julia Hillebrand et al.
JOURNAL OF ARTIFICIAL ORGANS (2015)
Heparin-Induced Thrombocytopenia
Andreas Greinacher
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin
Theodore E. Warkentin et al.
BLOOD (2014)
Heparin Sensitivity and Resistance: Management During Cardiopulmonary Bypass
Alan Finley et al.
ANESTHESIA AND ANALGESIA (2013)
Non-recovery of ACT in a patient with heparin-induced thrombocytopenia type II during mitral valve replacement using argatroban anticoagulation
Yoshinori Tanigawa et al.
JOURNAL OF ANESTHESIA (2013)
Thrombosis during off pump LVAD placement in a patient with heparin induced thrombocytopenia using bivalirudin
Hamdy Awad et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2013)
A modified technique for implantation of the HeartWare™ left ventricular assist device when using bivalirudin anticoagulation in patients with acute heparin-induced thrombocytopenia
Michiel Morshuis et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2013)
Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: Treprostinil is a potent DP1 and EP2 agonist
Brendan J. Whittle et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Direct thrombin inhibitors
Catherine J. Lee et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: An analysis of nearly 6000 patients undergoing coronary artery bypass grafting
Eivind Ovrum et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)
Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy
Lars Knudsen et al.
BMC PULMONARY MEDICINE (2011)
Pharmacology of argatroban
Walter P. Jeske et al.
EXPERT REVIEW OF HEMATOLOGY (2010)
Update on the clinical development of cangrelor
Masafumi Ueno et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
The paradox of heparin-induced thrombocytopenia
T. E. Warkentin
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade
Marion Durand et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2008)
Prostacyclin therapies for the treatment of pulmonary arterial hypertension
M. Gomberg-Maitland et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies
Cornelius M. Dyke et al.
ANNALS OF THORACIC SURGERY (2007)
Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: Results of the CHOOSE-ON trial
Andreas Koster et al.
ANNALS OF THORACIC SURGERY (2007)
Use of heparin and platelet GPIIbIIIa inhibitor tirofiban for cardiac surgery in patients for suspicion of heparin-induced thrombocytopenia
P. -L. Commin et al.
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION (2006)
Heparin-induced thrombocytopenia
Gowthami M. Arepally et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: The results of the EVOLUTION-OFF study
NG Smedira et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2006)
A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: The EVOLUTION-ON study
CM Dyke et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2006)
Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery
AF Merry et al.
ANNALS OF THORACIC SURGERY (2004)
Randomized COMparison of platelet inhibition with abciximab, TiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes - The COMPARE trial
WB Batchelor et al.
CIRCULATION (2002)
One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II
A Koster et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)
Temporal aspects of heparin-induced thrombocytopenia
TE Warkentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban
A Koster et al.
ANESTHESIOLOGY (2001)
Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia
A Aouifi et al.
ANNALS OF THORACIC SURGERY (2001)
The pharmacokinetics and pharmacodynamics of argatroban: Effects of age, gender, and hepatic or renal dysfunction
SK Swan et al.
PHARMACOTHERAPY (2000)
Share Paper
